Total Revenue

£203.5m

2014: £193.6m

CER*: Up 10.0%

£: Up 5.1%

2015 AR Dechra Total Revenue Barchart

EU Pharma Revenue

£168.6m

2014: £172.4m

CER*: Up 3.9%

£: Down 2.2%

2015 AR Dechra EU Pharma Revenue Barchart

NA Pharma Revenue

£34.9m

2014: £21.2m

CER*: Up 59.9%

£: Up 64.6%

2015 AR Dechra NA Pharma Revenue Barchart

Underlying Operating Profit

£44.4m

2014: £42.2m

CER*: Up 11.6%

£: Up 5.2%

2015 AR Dechra Underlying Operating Profit Barchart

Underlying Diluted Earnings per Share

39.90p

2014: 36.32p

CER*: Up 16.9%

£: Up 9.9%

2015 AR Dechra Underlying Diluted Earnings Per Share Barchart

Dividend per Share

16.94p

2014: 15.40p

CER*: Up 10.0%

£: Up 10.0%

2015 AR Dechra Dividend Per Share Barchart

* CER is defined as Constant Exchange Rate against prior year, whilst £ is at reported, Actual Exchange Rate (AER). A reconciliation of underlying to reported measures can
be found within our Financial Review.